Stocks
Medpace Holdings, Inc.

Medpace Holdings, Inc.MEDP

NASDAQHealthcareBiotechnology$587.52+1.48%

Price as of · delayed, not real-time

A clinical research organization (CRO) providing outsourced services for drug and medical device development, Medpace Holdings supports biopharmaceutical and biotechnology firms globally. The company is known for its full-service model spanning Phase I-IV clinical trials, attracting investor attention as a key player in the growing CRO market. Its performance is often viewed as a barometer for R&D spending trends in the biopharma sector.

Market Cap: $12.8B52W Range: $373.00-$677.90

Congressional Interest in Medpace Holdings, Inc. (MEDP)

7 members of Congress have disclosed 26 trades in Medpace Holdings, Inc. (MEDP), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 13 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
26
Unique Politicians
7
Buys
13
Sells
13

Who in Congress Is Trading MEDP?

2026-05-15$1K-$15K
Stock
2026-05-15$1K-$15K
Stock
2026-02-26$1K-$15K
Stock
2026-01-29$1K-$15K
Stock
2026-01-16$1K-$15K
Stock
2026-01-15$15K-$50K
Stock
2025-10-09$1K-$15K
Stock
2025-08-04$1K-$15K
Stock
2025-07-24$1K-$15K
Stock
2025-07-23$1K-$15K
Stock
2025-07-22$1K-$15K
Stock
2025-01-13$1K-$15K
Stock
2024-07-26$1K-$15K
Stock
2024-06-21$1K-$15K
Stock
2024-01-24$1K-$15K
Stock
2023-11-13$1K-$15K
Stock
2022-07-22$1K-$15K
Stock
2021-10-26$1K-$15K
Stock
2020-12-10$1K-$15K
Stock
2020-12-08$1K-$15K
Stock
2020-11-03$1K-$15K
Stock
2020-10-29$1K-$15K
Stock
2020-10-13$1K-$15K
Stock
2020-08-03$1K-$15K
Stock
2020-08-03$1K-$15K
Stock
2020-01-06$1K-$15K
Stock